Galera Phase 3 oral Mucositis. I was just looki
Post# of 72440
I was just looking at their trial and was surprised to see this.
"The purpose of the phase 3, clinical study is to determine if GC4419 administered prior to intensity-modulated radiation therapy (IMRT) reduces the severity of radiation induced oral mucositis in patients who have been diagnosed with locally advanced, non-metastatic squamous cell carcinoma of the head and neck."
So they aren't looking to reduce occurrences just severity?
Also their patient population # is 335.
With a proven rinse and spit and with a BP, IPIX can do this in a year or less.
B-OM will OWN the entire BILLION dollar market!!!!